BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wijarnpreecha K, Li F, Xiang Y, Xu X, Zhu C, Maroufy V, Wang Q, Tao W, Dang Y, Pham HA, Zhou Y, Li J, Zhang X, Xu H, Taner CB, Yang L, Tao C. Nonselective beta-blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States. Aliment Pharmacol Ther 2021;54:481-92. [PMID: 34224163 DOI: 10.1111/apt.16490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gillespie S, Hayes PC. Editorial: when to start carvedilol in cirrhosis—time to reconsider? Aliment Pharmacol Ther 2021;54:726-7. [DOI: 10.1111/apt.16512] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Wijarnpreecha K, Li F, Taner CB, Yang L, Tao C. Editorial: when to start carvedilol in cirrhosis-time to reconsider? Authors' reply. Aliment Pharmacol Ther 2021;54:728-9. [PMID: 34379839 DOI: 10.1111/apt.16526] [Reference Citation Analysis]
3 Lelou E, Corlu A, Nesseler N, Rauch C, Mallédant Y, Seguin P, Aninat C. The Role of Catecholamines in Pathophysiological Liver Processes. Cells 2022;11:1021. [DOI: 10.3390/cells11061021] [Reference Citation Analysis]